B

BioCryst Pharmaceuticals
D

BCRX

7.62000
USD
0.02
(0.20%)
مغلق
حجم التداول
61,050
الربح لكل سهم
-0
العائد الربحي
-
P/E
-12
حجم السوق
1,578,350,191
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    -3.460
    (-2.00%)
    169.130 USD
    AMGN
    AMGN
    -1.26
    (-0.46%)
    273.59 USD
    BMY
    BMY
    0.025
    (0.04%)
    57.075 USD
    GILD
    GILD
    0.070
    (0.08%)
    93.020 USD
    MRK
    MRK
    -0.560
    (-0.58%)
    95.670 USD
    NVS
    NVS
    -1.600
    (-1.60%)
    98.180 USD
    PFE
    PFE
    -0.621
    (-2.33%)
    26.015 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    المزيد
الأخبار
المقالات

العنوان: BioCryst Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.